List of adverse effects of chlorpromazine

Last updated

Chlorpromazine includes the following list of adverse effects (serious adverse effects appear in bold): [Note 1] [1] [2] [3] [4] [5]

Contents

Very common

Common

Uncommon

Rare

Unknown frequency

Notes

  1. Data on the exact incidence of the different adverse effects is greatly lacking so only rough approximations of adverse effect incidence is available
  2. Refer to main text below for details on this adverse effect
  3. A drop in blood pressure that results from standing up
  4. A disturbance in the electrical cycle of the heart
  5. Elevated serum levels of the lactation-related hormone prolactin. This in turn can result, in the short term, at least, in galactorrhoea (lactation that is unrelated to pregnancy or breastfeeding), gynaecomastia (swollen breast tissue), sexual dysfunction and amenorrhoea (the absence of the menstrual period in women). Whereas in the long-term hyperprolactinaemia can result in osteoporosis (brittle bones).
  6. An impaired ability to regulate one's body temperature
  7. High blood glucose (sugar) levels
  8. The hypothalamus of the brain regulates the release of a number of hormones as well as a few "housekeeping" functions such as tight control over body temperature
  9. Widening (dilation) of the pupils
  10. Refer to the text below for details
  11. Constriction of the pupils of the eyes
  12. Being unable to pass urine
  13. Glucose (sugar) in the urine due to there being too much glucose in the blood for the kidneys to reabsorb it all when filtrate goes through loop of henle in the nephrons of the kidney.
  14. Low blood glucose (sugar)
  15. Basically an exaggerated form of leucopaenia. It occurs when the white blood cell (WBC) count drops below 5% of the norm
  16. Where the number of red blood cells of the body die breakdown to an abnormal extent. These cells carry oxygen across the body from the lungs
  17. Where the bone marrow stops adequately (in order to replenish the blood cells that die off every day) producing new blood cells
  18. An abnormality in the electrical activity of the heart which can lead to potentially fatal changes in heart rhythm
  19. Dangerously (in the short-term) high blood pressure
  20. A dangerous skin reaction
  21. An autoimmune reaction
  22. A potentially fatal collection of symptoms (i.e. syndrome) that results from an abnormally excessive release of antidiuretic hormone (ADH). This in turn increases the reabsorption of
  23. A potentially fatal condition that is caused by dopamine receptor-blocking agents such as antipsychotics. It develops over a period of days or weeks and is characterised by rigidity, tremor, diarrhoea, tachycardia, altered mental status (e.g. confusion, mania, hallucinations, etc.) and hyperthermia (high body temperature)
  24. An autoimmune condition in of which the body's defences attack the neuromuscular junction – the gap between muscle and nerve cells across which the nerves send messages to the muscle cells
  25. An abnormally low number of white blood cells in the blood. These cells defend the body from infections and hence this can heighten one's risk of infections
  26. An abnormally high number of eosinophils – the cells of the immune system that defends the body from parasites
  27. An abnormally low number of all three major groups of blood cells including the red blood cells, white blood cells and platelets
  28. A painful and sustained (usually a few hours) erection
  29. Fear of light
  30. A reduction in the normal homeostatic breathing reaction to reductions in plasmacarbon dioxide levels
  31. High body temperature
  32. Low body temperature
  33. Lactation that is unassociated with lactation or breastfeeding
  34. The accumulation of fluid in the tissues of the brain
  35. Basically the opposite to euphoria
  36. The absence of menstrual periods
  37. An often irreversible and sometimes even fatal movement disorder characterised by involuntary, repetitive and purposeless movements of the face, extremities, lips or tongue. Usually takes a number of years to develop but in some it can appear within months or less since the initiation of antipsychotic treatment

Related Research Articles

Chlorpromazine Antipsychotic medication

Chlorpromazine (CPZ), marketed under the brand names Thorazine and Largactil among others, is an antipsychotic medication. It is primarily used to treat psychotic disorders such as schizophrenia. Other uses include the treatment of bipolar disorder, severe behavioral problems in children including those with attention deficit hyperactivity disorder, nausea and vomiting, anxiety before surgery, and hiccups that do not improve following other measures. It can be given by mouth, by injection into a muscle, or into a vein.

Sertindole

Sertindole, sold under the brand name Serdolect among others, is an antipsychotic medication. Sertindole was developed by the Danish pharmaceutical company Lundbeck and marketed under license by Abbott Labs. Like other atypical antipsychotics, it has activity at dopamine and serotonin receptors in the brain. It is used in the treatment of schizophrenia. It is classified chemically as a phenylindole derivative.

Amoxapine

Amoxapine, sold under the brand name Asendin among others, is a tricyclic antidepressant (TCAs). It is the N-demethylated metabolite of loxapine. Amoxapine first received marketing approval in the United States in 1992.

Promethazine First-generation antihistamine and antiemetic

Promethazine is a first-generation antihistamine and antiemetic used to treat allergies, insomnia, and nausea. It was once widely used as an antipsychotic, although it is generally not used for this purpose now. It has approximately 1/10 the antipsychotic strength of chlorpromazine. It may also help with some symptoms associated with the common cold and may also be used for sedating people who are agitated or anxious. Promethazine is available by mouth in syrup or tablet dosage forms, as a rectal suppository, or by injection into a muscle.

Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is characterized by excessive unsuppressible release of antidiuretic hormone (ADH) either from the posterior pituitary gland, or an abnormal non-pituitary source. Unsuppressed ADH causes an unrelenting increase in solute-free water being returned by the tubules of the kidney to the venous circulation.

Sulpiride Atypical antipsychotic

Sulpiride, sold under the brand name Dogmatil among others, is an atypical antipsychotic medication of the benzamide class which is used mainly in the treatment of psychosis associated with schizophrenia and major depressive disorder, and sometimes used in low dosage to treat anxiety and mild depression. Sulpiride is commonly used in Asia, Central America, Europe, South Africa and South America. Levosulpiride is its purified levo-isomer and is sold in India for similar purpose. It is not approved in the United States, Canada, or Australia. The drug is chemically and clinically similar to amisulpride.

Flupentixol Typical antipsychotic drug of the thioxanthene class

Flupentixol (INN), also known as flupenthixol, marketed under brand names such as Depixol and Fluanxol is a typical antipsychotic drug of the thioxanthene class. It was introduced in 1965 by Lundbeck. In addition to single drug preparations, it is also available as flupentixol/melitracen—a combination product containing both melitracen and flupentixol. Flupentixol is not approved for use in the United States. It is, however, approved for use in the UK, Australia, Canada, Russian Federation, South Africa, New Zealand, Philippines and various other countries.

Promazine

Promazine, is used as a short-term add-on treatment for psychomotor agitation. Its approved uses in people is limited, but is used as a tranquilizer in veterinary medicine. It has weak antipsychotic effects but is generally not used to treat psychoses.

Zuclopenthixol Chemical compound

Zuclopenthixol, also known as zuclopentixol, is a medication used to treat schizophrenia and other psychoses. It is classed, pharmacologically, as a typical antipsychotic. Chemically it is a thioxanthene. It is the cis-isomer of clopenthixol. Clopenthixol was introduced in 1961, while zuclopenthixol was introduced in 1978.

Vilazodone Medication used to treat major depressive disorder

Vilazodone, sold under the brand name Viibryd among others, is a medication used to treat major depressive disorder. While it was being studied for generalized anxiety disorder, such research had stopped as of 2017. It is taken by mouth.

Paricalcitol

Paricalcitol (chemically it is 19-nor-1,25-(OH)2-vitamin D2. Marketed by Abbott Laboratories under the trade name Zemplar) is a drug used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic kidney failure. It is an analog of 1,25-dihydroxyergocalciferol, the active form of vitamin D2 (ergocalciferol).

Amitriptyline/perphenazine

Amitriptyline/perphenazine is a formulation that contains the tricyclic antidepressant amitriptyline and the medium-potency typical (first-generation) antipsychotic, perphenazine. In the United States amitriptyline/perphenazine is marketed by Mylan Pharmaceuticals Inc. and Remedy Repack Inc.

References

  1. "PRODUCT INFORMATION LARGACTIL" (PDF). TGA eBusiness Services. Sanofi Aventis Pty Ltd. 28 August 2012. Retrieved 8 December 2013.
  2. "Chlorpromazine Hydrochloride 100mg/5ml Oral Syrup - Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Rosemont Pharmaceuticals Limited. 6 August 2013. Retrieved 8 December 2013.
  3. "CHLORPROMAZINE HYDROCHLORIDE tablet, film coated [Sandoz Inc]". DailyMed. Sandoz Inc. October 2011. Retrieved 8 December 2013.
  4. "CHLORPROMAZINE HYDROCHLORIDE injection [West-ward Pharmaceutical Corp.]". DailyMed. West-ward Pharmaceutical Corp. June 2012. Retrieved 8 December 2013.
  5. "Largactil Injection - Summary of Product Characteristics". electronic Medicines Compendium. Sanofi. 10 May 2013. Retrieved 8 December 2013.